Brent T Mausbach1, Scott A Irwin1,2. 1. Department of Psychiatry, University of California San Diego, and Patient and Family Support Services, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. 2. Department of Psychiatry and Samuel Oschin Comprehensive Cancer Institute's Supportive Care Services, Cedars-Sinai Health System, USA.
Abstract
OBJECTIVE: It is estimated that as many as 38% of cancer patients suffer from depression, which may have distal impacts on cancer care, including clinical outcomes, health care utilization, and cost of care. The purpose of this study was to determine the impact of depression on overall healthcare utilization among patients with cancer. METHODS: A retrospective analysis of administrative data was conducted on 5055 patients with an ICD-9 diagnosis of cancer from a single large healthcare system. Of these, 561 (11.1%) had ICD-9 diagnoses consistent with a depressive disorder. Negative binomial regression modeling was used to test the association between depression status and total annual healthcare visits for the year 2011. Logistic regression was used to examine the association between depression and secondary outcomes of emergency department visit, overnight hospitalization, and 30-day hospital readmission. RESULTS: After adjusting for age, gender, race/ethnicity, insurance type, medical comorbidities, length of time with cancer, and metastatic status, depressed patients had significantly more annual non-mental health provider healthcare visits (aRR = 1.76, 95% CI = 1.61-1.93), and were significantly more likely to have an ED visit (OR = 2.45; 95% CI = 1.97-3.04), overnight hospitalization (OR = 1.81; 95% CI = 1.49-2.20), and 30-day hospital readmission (OR = 2.03; 95% CI = 1.48-2.79) than non-depressed patients with cancer. CONCLUSIONS: Among patients with cancer, the presence of depression was associated with greater healthcare utilization. Effective screening for, and management of, depression may help reduce overall healthcare utilization and cost while improving care quality.
OBJECTIVE: It is estimated that as many as 38% of cancerpatients suffer from depression, which may have distal impacts on cancer care, including clinical outcomes, health care utilization, and cost of care. The purpose of this study was to determine the impact of depression on overall healthcare utilization among patients with cancer. METHODS: A retrospective analysis of administrative data was conducted on 5055 patients with an ICD-9 diagnosis of cancer from a single large healthcare system. Of these, 561 (11.1%) had ICD-9 diagnoses consistent with a depressive disorder. Negative binomial regression modeling was used to test the association between depression status and total annual healthcare visits for the year 2011. Logistic regression was used to examine the association between depression and secondary outcomes of emergency department visit, overnight hospitalization, and 30-day hospital readmission. RESULTS: After adjusting for age, gender, race/ethnicity, insurance type, medical comorbidities, length of time with cancer, and metastatic status, depressedpatients had significantly more annual non-mental health provider healthcare visits (aRR = 1.76, 95% CI = 1.61-1.93), and were significantly more likely to have an ED visit (OR = 2.45; 95% CI = 1.97-3.04), overnight hospitalization (OR = 1.81; 95% CI = 1.49-2.20), and 30-day hospital readmission (OR = 2.03; 95% CI = 1.48-2.79) than non-depressedpatients with cancer. CONCLUSIONS: Among patients with cancer, the presence of depression was associated with greater healthcare utilization. Effective screening for, and management of, depression may help reduce overall healthcare utilization and cost while improving care quality.
Authors: M P Luber; J P Hollenberg; P Williams-Russo; T N DiDomenico; B S Meyers; G S Alexopoulos; M E Charlson Journal: Int J Psychiatry Med Date: 2000 Impact factor: 1.210
Authors: A Matthew Prina; Martijn Huisman; Bu B Yeap; Graeme J Hankey; Leon Flicker; Carol Brayne; Osvaldo P Almeida Journal: CMAJ Date: 2012-12-10 Impact factor: 8.262
Authors: M Ansseau; M Dierick; F Buntinkx; P Cnockaert; J De Smedt; M Van Den Haute; D Vander Mijnsbrugge Journal: J Affect Disord Date: 2004-01 Impact factor: 4.839
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: A Matthew Prina; Theodore D Cosco; Tom Dening; Aartjan Beekman; Carol Brayne; Martijn Huisman Journal: J Psychosom Res Date: 2014-11-08 Impact factor: 3.006
Authors: Anita R Peoples; Sheila N Garland; Wilfred R Pigeon; Michael L Perlis; Julie Rya Wolf; Kathi L Heffner; Karen M Mustian; Charles E Heckler; Luke J Peppone; Charles S Kamen; Gary R Morrow; Joseph A Roscoe Journal: J Clin Sleep Med Date: 2019-01-15 Impact factor: 4.062
Authors: Cara L McDermott; Aasthaa Bansal; Scott D Ramsey; Gary H Lyman; Sean D Sullivan Journal: J Pain Symptom Manage Date: 2018-08-17 Impact factor: 3.612
Authors: Melissa M Garrido; Holly G Prigerson; Suvam Neupane; Joan D Penrod; Christopher E Johnson; Kenneth S Boockvar Journal: J Palliat Med Date: 2016-11-11 Impact factor: 2.947
Authors: Kelly M Trevino; Charlotte Healy; Peter Martin; Beverly Canin; Karl Pillemer; Jo Anne Sirey; M Cary Reid Journal: J Geriatr Oncol Date: 2018-09 Impact factor: 3.599
Authors: Brent T Mausbach; Gabrielle Decastro; Richard B Schwab; Maria Tiamson-Kassab; Scott A Irwin Journal: Depress Anxiety Date: 2020-06-02 Impact factor: 6.505
Authors: Florie E Van Beek; Lonneke M A Wijnhoven; Karen Holtmaat; José A E Custers; Judith B Prins; Irma M Verdonck-de Leeuw; Femke Jansen Journal: Psychooncology Date: 2021-07-06 Impact factor: 3.955